Company Filing History:
1 out of 5,072 
1 out of 1,743 
Years Active: 2024
Title: Charbel Massaad: Innovator in Antisense RNA Technology
Introduction
Charbel Massaad is a notable inventor based in Arcueil, France. He has made significant contributions to the field of biotechnology, particularly in the development of antisense RNA therapies. His work focuses on innovative solutions for genetic disorders, showcasing his commitment to advancing medical science.
Latest Patents
Charbel Massaad holds a patent for "Antisense RNA targeting PMP22 for the treatment of Charcot-Marie-Tooth 1A disease." This invention relates to antisense RNAs that target PMP22 and can inhibit the expression of this gene by 40% to 60% in cells. The patent emphasizes the use of siRNA, preferably delivered in the form of nanoparticles, to treat Charcot-Marie-Tooth 1A disease effectively.
Career Highlights
Throughout his career, Charbel has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and the Institut National de la Santé et de la Recherche Médicale. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Charbel's notable coworkers include Liliane Massade and Susan Boutary. Their collaborative efforts have furthered the research and development of innovative therapies in the realm of genetic disorders.
Conclusion
Charbel Massaad's work in antisense RNA technology represents a significant advancement in the treatment of genetic diseases. His dedication to innovation and collaboration continues to inspire progress in the medical field.